Erman Akkus

Ankara, Turkey

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications

Different Stage But Similar Survival in Hepatocellular Carcinoma: A Dilemma of Treatment Timing?

Different Stage But Similar Survival in Hepatocellular Carcinoma: A Dilemma of Treatment Timing?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 10, 2026

Neoadjuvant GOLP in Intrahepatic Cholangiocarcinoma.

Neoadjuvant GOLP in Intrahepatic Cholangiocarcinoma.

Journal: The New England journal of medicine
Published: May 27, 2026

Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO).

Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO).

Journal: JCO global oncology
Published: March 26, 2026

Imposter Syndrome, Burnout, and Maladaptive Perfectionism Among Oncology Professionals: A Global Cross-Sectional Study.

Imposter Syndrome, Burnout, and Maladaptive Perfectionism Among Oncology Professionals: A Global Cross-Sectional Study.

Journal: JCO oncology practice
Published: February 25, 2026

Vaccination in patients with cancer: Gaps in coverage, barriers, and the role of clinician recommendations.

Vaccination in patients with cancer: Gaps in coverage, barriers, and the role of clinician recommendations.

Journal: Human vaccines & immunotherapeutics
Published: February 13, 2026

Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study (TOG/GI-SAFRADJU-2501).

Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study (TOG/GI-SAFRADJU-2501).

Journal: International journal of cancer
Published: February 09, 2026

Second-line TKI after first-line immunotherapy-based treatment in advanced HCC: Reconstructed IPD meta-analysis.

Second-line TKI after first-line immunotherapy-based treatment in advanced HCC: Reconstructed IPD meta-analysis.

Journal: JHEP reports : innovation in hepatology
Published: December 16, 2025

Individualized Triplet Chemotherapy Decision-Making in Metastatic Colorectal Cancer: A Machine-Learning-Driven Study.

Individualized Triplet Chemotherapy Decision-Making in Metastatic Colorectal Cancer: A Machine-Learning-Driven Study.

Journal: Cancers
Published: October 15, 2025

Somatic variants and frequencies of familial myeloma germline predisposition genes among patients within the CoMMpass dataset.

Somatic variants and frequencies of familial myeloma germline predisposition genes among patients within the CoMMpass dataset.

Journal: Expert review of hematology
Published: September 25, 2025

Assessing the Influence of Proton Pump Inhibitors on Clinical Outcomes in Hormone Receptor-Positive Metastatic Breast Cancer Patients Receiving CDK4/6 Inhibitors: Evidence from a Ribociclib-Dominant Cohort.

Assessing the Influence of Proton Pump Inhibitors on Clinical Outcomes in Hormone Receptor-Positive Metastatic Breast Cancer Patients Receiving CDK4/6 Inhibitors: Evidence from a Ribociclib-Dominant Cohort.

Journal: Medicina (Kaunas, Lithuania)
Published: September 12, 2025

Assessment of Fear of Cancer Recurrence in Patients with Colorectal Cancer and Its Association with Pet Ownership: A Cross-Sectional Study.

Assessment of Fear of Cancer Recurrence in Patients with Colorectal Cancer and Its Association with Pet Ownership: A Cross-Sectional Study.

Journal: Current oncology (Toronto, Ont.)
Published: August 23, 2025

Metabolic dysfunction-associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad.

Metabolic dysfunction-associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad.

Journal: European journal of clinical investigation
Published: August 10, 2025
Showing 1-12 of 53

Last Updated: 09/26/2026